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ABSTRACT   Rapid recognition of bacteremia is important for critical care, especially in 
patients with suspected bloodstream infections. Procalcitonin and presepsin are widely used 
biomarkers in point-of care medical testing for identifying infectious diseases and sepsis; 
however, the diagnostic accuracy for the prediction of bacteremia is not well established. 
Therefore, this study aimed to evaluate the diagnostic accuracy of procalcitonin and presepsin 
for the prediction of bacteremia in patients with suspected bacteremia. We performed a 
prospective observational study at our hospital. A total of 210 patients (307 samples) who had 
been admitted from December 2014 through September 2016 with a suspected infection were 
included. Presepsin and procalcitonin were tested simultaneously with blood cultures and 
routine laboratory tests. One hundred and four blood samples were obtained at the emergency 
room (ER). Others were obtained during hospital admission. Blood cultures were positive in 
34 samples; 25 samples were obtained in the ER. Presepsin and procalcitonin levels were 
significantly higher in patients with positive blood cultures than in those with negative blood 
cultures (1028.5 pg/mL vs. 485.0 pg/mL, P  < 0.001 and 4.53 ng/mL vs. 0.33 ng/mL, P  < 0.001, 
respectively). For predicting bacteremia, receiver operating characteristic curve analysis for 
presepsin showed an area under the curve (AUC) of 0.718 and negative predictive value (NPV) 
of 95%. The analysis for procalcitonin showed an AUC of 0.778 and NPV of 94.8%. C-reactive 
protein tests and the quick Sequential Organ Failure Assessment score in the ER failed to 
be useful tools for predicting bacteremia. Based on our results, procalcitonin and presepsin 
showed good diagnostic accuracy and NPV for predicting bacteremia among patients with 
suspected infection. Therefore, these biomarkers may be useful for ruling out bacteremia in 
patients with suspected infection. doi：10.11482/KMJ-E201945027　(Accepted on June 8, 2019)
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InTroducTIon
   In 1914 ,  Budelmann１） defined sepsis as 
septicemia, a disease resulting from the infiltration 
of microorganisms into the bloodstream. Subsequent 
medical advances have resulted in significant 
changes to this definition, and the 2012 Surviving 
Sepsis Campaign Guidelines described this 
condition as “probable (documented or suspected) 
infection and signs of systemic inflammation”２）. 
In February 2016, the new Sepsis-3 definition 
resulted in the disease being limited to patients with 
severe sepsis３）. As proposed by Budelmann１）, 
the infiltration of a microorganism into the 
bloodstream is now termed bacteremia and is no 
longer a prerequisite for diagnosing sepsis due to 
the poor sensitivity of blood culture３）. However, 
some serious infectious diseases, such as primary 
bacteremia, infective endocarditis, or catheter-
related blood stream infections, are difficult to 
diagnose with only physical examinations; these are 
all diagnosed with a positive blood culture. Patients 
with such underlying conditions may benefit from 
early diagnosis of bacteremia. Additionally, it has 
been reported that in ICU patients, bacteremia is a 
risk factor for increased mortality and prolonged 
ICU stay４）. In this setting, rapid diagnosis of 
not only sepsis but also bacteremia is important. 
However, several days are needed to obtain the 
blood culture result.
   Some novel technologies including DNA 
analysis may be used to help predict blood culture 
results５）. However, DNA analysis is expensive and 
complicated; therefore, it is difficult to implement it 
in a clinical setting.
   Biomarkers such as C-reactive protein (CRP), 
presepsin (PSEP), and procalcitonin (PCT) are 
available in clinical settings for speedy and easy 
point-of-care testing. Specifically, PCT is a widely 
recognized biomarker of sepsis３）. 
   PSEP (a  subtype of  soluble  CD14 )  i s  a 
g lycopro te in  wi th  a  molecu la r  we igh t  o f 
approximately 13 kDa. High PSEP blood levels are 
thought to be observed in sepsis patients. PSEP is 
thought to appear in the blood when stimulation by 
an infection leads to shedding of CD14 from the cell 
membrane６）.
   PSEP levels rise 12 hours to several days earlier 
than PCT levels, and it has been reported in burn 
patients７）. The ability of PCT to predict blood 
culture positivity has been examined in some 
specific disease such as febrile neutropenia８－10）. 
However, few studies have been conducted on 
the diagnostic ability of PSEP for bacteremia. 
Therefore, this study aimed to determine the ability 
of two promising biomarkers, namely PSEP and 
PCT, to predict bacteremia in patients suspected of 
having bacteremia. 
SubjecTS and meThodS
Inclusion and exclusion criteria
   Our study comprised patients who had been 
hospitalized in the Advanced Critical Care Center 
at Kawasaki Medical School Hospital in Okayama, 
Japan, from December 2014 through September 
2016 and had been performed blood cultures due 
to suspected bacteremia upon admission or during 
hospitalization. Only patients who had a negative 
follow-up blood culture were excluded. This 
study was conducted according to the principles 
of the Declaration of Helsinki and approved 
by the Institutional Review Board of Kawasaki 
Medical School (approval no: 1926-2). At the time 
of admission, all patients were provided with an 
advanced explanation regarding this study; written 
consent was obtained from each patient.
Study design and data collection
   Blood culture samples obtained from patients 
with suspected bacteremia in the ER, intensive care 
unit, or ward were included in this single-center, 
prospective, observational study. Each sample was 
included in our study from a single time-point or 
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independent episode. Patients who had multiple 
independent episodes of suspected bacteremia 
were separately enrolled. Whether a blood culture 
examination should be conducted for each patient 
depended on the clinical decision of the attending 
physician. Therefore, this study protocol had no 
effect on the decision regarding whether to perform 
a blood culture. In addition to general blood test 
including white blood cell count assessment, 
patient characteristics, diagnosis of admission, vital 
signs, suspected site of infection and biomarkers 
(CRP, PSEP, and PCT) were measured at the same 
time the blood culture was performed. Medical 
care was provided as normal, based upon the 
judgment of each patient’s attending physician. The 
primary outcome of this study was to evaluate the 
diagnostic accuracy of biomarkers (PSEP and PCT) 
for bacteremia at the time of clinical physician 
suspected bacteremia. In addition, we assessed the 
outcomes associated with the blood culture.
Blood Culture
   Ethanol containing 1% chlorhexidine gluconate 
was generally used for routine disinfection. A 
solution containing 10% povidone iodine was used 
as an alternative when the routine disinfectant was 
contraindicated. For all patients, two sets of blood 
samples were collected from different sites (for 
each set, a ≥   16 mL blood sample was dispensed 
into an aerobic and anaerobic bottle) and submitted 
for blood culture testing. We used BD ™ Bactec ™ 
Media: Plus Aerobic/F blood culture bottles (Nippon 
Becton Dickinson Company, Ltd., Tokyo, Japan). 
Results were assessed after culturing the samples 
for 7 days. Among the positive blood culture results, 
those deemed clearly contaminated, based on 
culture results and the patient’s clinical course, were 
excluded.
Psep
   Point-of-care PSEP measurement was performed 
using a PATHFAST immunoanalyzer (LSI Medience 
Corporation, Tokyo, Japan) immediately after 
whole blood (collected along with the blood culture 
testing) was collected in an EDTA blood collection 
tube. The assay detects PSEP levels of 20-20,000 
pg/mL, with a cut off value of 500 ng/L for sepsis 
diagnosis. Hematocrit correction was performed for 
all samples.
Pct
   S e r u m  P C T  w a s  m e a s u r e d  u s i n g  a n 
electrochemiluminescence immunoassay (SRL, Inc, 
Tokyo, Japan). The lower limit of measurement was 
0.02 ng/mL, and the normal range was < 0.05 ng/
mL. The threshold for diagnosing bacterial sepsis 
was ≥   0.5 ng/mL.
Statistical Analysis
   Sample size was calculated to achieve a power of 
1-β of 0.90, area under the curve (AUC) of 0.70, 
α value of 0.05, and kappa (blood culture negative/
blood culture positive) coefficient of 9. Under these 
assumptions, the sample size was estimated at 232. 
Because the primary outcome of this study was the 
diagnostic accuracy of biomarkers for bacteremia 
from blood culture samples, which is not affected 
by clinical characteristics of patients, we analyzed 
each sample from each event as independent data. 
Results are presented as actual values for categories 
and as percentages and medians (first quartile to 
third quartile). All results were divided into two 
groups: blood culture-positive and blood culture-
negative groups. False-positive blood culture results 
were judged according to the clinical course and 
detected pathogen, and the data were added to the 
blood culture-negative group. When performing an 
inter-group analysis, the Mann-Whitney U-test (two-
tailed) was used for non-normally distributed data. 
When investigating ratios, Pearson’s chi-squared 
test or Fisher’s exact test was used. Missing values 
were left as they were without imputation. Receiver 
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operating characteristic (ROC) curve analysis was 
used to test diagnostic capability, and Youden’s 
index was used to determine associated cut-off 
values. We also calculated the sensitivity, specificity, 
positive predictive value (PPV), and negative 
predictive value (NPV) for the determined cut-off 
values. Statistical analysis was performed using 
SPSS statistical package 25.0 (IBM), and a P-value 
< 0.05 was considered statistically significant.
reSuLTS
   Blood cultures were performed for 210 patients 
upon admission or while hospitalized during the 
study period (median age, 70.5 years; interquartile 
range [IQR], 50-80; males, 134; females, 76). A total 
of 153 patients had undergone sample collection 
for blood culture multiple times for completely 
unrelated episodes. Therefore, we investigated 307 
consecutive samples. The most common source of 
infection suspected during blood culture collection 
was pneumonia (126 samples), followed by urinary 
tract infection (42 samples) and wound infection (37 
samples) (Table 1).
   Table 2 shows the clinical data for blood culture-
positive and blood culture-negative groups in 
comparison with the expected infection sources. 
There were 35 blood-culture positive specimens; 25 
were obtained during outpatient care at the ER. Only 
1 sample obtained during admission was determined 
to be a false positive (0.3%) because of the detected 
pathogen (Bacillus species) and the patient’s clinical 
course. Therefore, it was included in blood culture-
negative group. As a result, 34 blood culture-positive 
specimens were included in analysis. Positive blood 
culture samples were reported in 12 (26.7%) of 
the 45 patients with a qSOFA score of ≥   2 points 
and 13 (22.0%) of 59 patients with a qSOFA score 
of only 0 or 1 (P = 0.647). Heart rate, hematocrit, 
and serum creatinine and C-reactive protein (CRP) 
levels were significantly high in the blood culture-
positive group. Gram-positive bacteria were isolated 
from 19 samples, gram-negative bacteria from 12, 
and multiple bacteria were detected in 3 samples 
(Table 3). 
Table 1. Patient characteristics
Patients (n = 210) 　Laboratory data, median (IQR)
　Age (years) at admission, median (IQR) 70.5 (50-80) 　　White blood cell count (/μL) 10,940 (8,110–13,920)
　Sex, n (male %) 134 (63.8) 　　Hematocrit (%) 31.05 (27.3–37.1)
consecutive samples (n = 307) 　　Creatinine (mg/dL) 0.66 (0.48–1.10)
　Age (years) at admission, median (IQR) 71 (50–80) 　　C-reactive protein (mg/dL) 8.83 (4.26–15.95)
　Sex, n (male %) 204 (67.1) 　Suspected site of infection, n (%)
　Diagnosis on admission, n (%) 　　Lung 126 (41.4)
　　Trauma 176 (57.3) 　　Abdomen　 19 (6.3)
　　Infectious disease 83 (27.0) 　　Urinary tract　 42 (13.8)
　　Others 48 (15.6) 　　Blood infection/endocardium/catheter/implant device 11 (3.6)
　Obtained in the ER, n (%) 104 (33.9) 　　Central nerve 10 (3.3)
　　qSOFA score, n 　　Osteoarticular 6 (2.0)
　　　　　0 18 　　Skin 29 (9.5)
　　　　　1 41 　　Wound 37 (12.2)
　　　　　2 38 　　Other 27 (8.9)
　　　　　3 7
Vital signs, median (IQR)
　Body temperature (degree Celsius) 38.5 (34.4–39.0)
　Heart rate (beats/min) 96 (80–110)
　Systolic blood pressure (mmHg) 128 (109–149)
　Respiratory rate (breaths /min) 21 (17–27)
IQR, interquartile range; ER, emergency room; qSOFA, quick Sequential Organ Failure Assessment
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   Both presepsin and procalcitonin levels were 
significantly higher in blood culture-positive patients 
than in blood culture-negative samples (1028.5 pg/
mL vs. 485.0 pg/mL, P < 0.001 and 4.53 ng/mL vs. 
0.33 ng/mL, P < 0.001, respectively) (Fig. 1A and 
1B). ROC analysis was performed to investigate the 
accuracy of PSEP and PCT in predicting bacteremia. 
Results indicated the following: AUC of 0.778 (95% 
CI 0.696-0.860, P < 0.001) for PCT and an AUC of 
Table 2. Comparisons between blood culture-positive and blood culture-negative groups
Variable Negative (n = 273) Positive (n = 34) P-value Missing


















































Laboratory data, median (IQR)


























Suspected site of infection, n (%)
　Lung 122 (44.7) 4 (1.5) P = 0.0002
　Abdomen 16 (5.9) 3 (1.1) P = 0.4528
　Urinary tract 31 (11.4) 11 (4.0) P = 0.0024
　Blood infection/endocardium/catheter/implant device 11 (4.0) 0 (0) P = 0.6178
　Central nerve 10 (3.7) 0(0) P = 0.6091
　Osteoarticular 2 (0.7) 4 (1.5) P = 0.0016
　Skin 21 (7.7) 8 (2.9) P = 0.0078
　Wound 35 (12.8) 2 (0.7) P = 0.3994















ER, emergency room; qSOFA, quick Sequential Organ Failure Assessment; IQR, interquartile range
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0.718 (95% CI 0.634－0.803, P < 0.001) for PSEP 
(Fig. 2 and Table 4). Thus, no significant differences 
between PSEP and PCT were noted in the AUC 
results (P = 0.2373). Investigation of CRP levels 
indicated an AUC of 0.634 (95% CI 0.523－0.745, 
P < 0.009).
dIScuSSIon
   In this prospective observational study, PCT 
and PSEP showed good diagnostic accuracy and 
NPV for predicting bacteremia among patients 
with suspected bacteremia in the clinical setting. 
However, the results for CRP in this study (AUC 
0.634) did not indicate its superiority over PSEP or 
PCT for predicting bacteremia.
   While many studies have investigated the role 
of biomarkers such as PCT11，12）, PSEP11）, and 
interleukin 6 (IL-6)13） for the early diagnosis 
of sepsis, few studies have examined the use 
of biomarkers, particularly PSEP, for the early 
diagnosis of bacteremia. In a study targeting 
patients with sepsis who had been diagnosed in an 
emergency outpatient setting and treated according 
to the SIRS criteria, Leli et al.14） reported PCT 
levels of 23.7 ng/mL (6.9－101) in the blood 
culture-positive group and 0.34 ng/mL (0.05－2.1) 

























Fig. 2. ROC analysis for blood culture-positive results for 
presepsin, procalcitonin, and C-reactive protein.
Table 4. Diagnostic accuracy of biomarkers for the prediction of bacteremia
AUC 95% CI P-value Cut-off Sensitivity Specifi city PPV NPV
Procalcitonin 0.778 0.695–0.861 <0.001 1.045 0.676 0.733 0.240 0.948
Presepsin 0.718 0.633–0.804 <0.001 654 0.735 0.630 0.198 0.950
CRP 0.634 0.523–0.745 0.009 12.475 0.618 0.679 0.194 0.934








































Fig. 1. Distribution of presepsin (A) and procalcitonin (B) relative to blood culture results.
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in the blood culture-negative group, with an AUC of 
0.876. Congruently, PSEP levels were 1,290 pg/mL 
(1,005－2,041) in the positive group and 659 pg/
mL (381－979) in the negative group, with an AUC 
of 0.788. However, this study only targeted SIRS 
patients, who are no longer used in clinical settings. 
Additionally, as patients without SIRS can develop 
bacteremia, the patient group targeted in that study 
for measuring PSEP to make an early diagnosis of 
bacteremia may be inappropriate.
   Many studies have reported the usefulness of 
PCT in the early diagnosis of sepsis11－13） and 
bacteremia15，16）. Jeong et al.16） reported an AUC 
of 0.86 for the diagnostic precision of PCT for 
bacteremia with a cut-off value of 0.99 (ng/mL), 
which is similar to the results of our study that 
indicated an AUC of 0.778 and cut-off value of 1.045 
(ng/mL). 
   Our study considered patients who had undergone 
blood culture collection as patients suspected of 
infection and bacteremia. Churpek et al. suggested 
that sepsis specific early warning scores such 
as SOFA, SIRS score, and qSOFA were not 
significantly different among patients who had 
undergone some form of culture collection due to 
suspected infection, those who had undergone blood 
culture collection, and those who were administered 
antibacterial agents17）. Therefore, the results of our 
investigation for patients with suspected infection 
who had undergone blood culture collection are 
clinically useful. We indicated that the blood culture 
positivity rate was 11.1%, whereas previously 
reported positivity rates for blood culture samples 
in studies targeting sepsis patients were 17% for 
patients with sepsis, 25%－38% for patients with 
severe sepsis, and 69% for patients with septic 
shock18，19）. Additionally, the false-positive rate in 
the present study was 0.3%, which is appropriate 
considering the anticipated false-positive rate20）. In 
view of this, our targeting of patients with suspected 
infection and bacteremia appears to have largely 
been in line with standard clinical assessments on 
eligibility for blood culture testing.
   When the cut-off values determined in the 
present study were used, the NPV for both PCT 
and PSEP was good, at approximately 95%. It has 
been reported that 5.2% of patients administered 
antibacterial agents for a severe infection in the ICU 
did not actually have a bacterial infection21）. The 
additional use of biomarkers for such patients may 
help reduce the unnecessary use of broad-spectrum 
antimicrobials.
   This study had several limitations. First, we 
analyzed the use of general blood culture results for 
determining bacteremia as the outcome investigated 
in this study. Blood culture testing has been reported 
to have low sensitivity for determining bacteremia. 
Therefore, our results are likely to include a certain 
percentage of false negatives. In the future, methods 
such as real-time PCR could be implemented to 
avoid false-negative results. 
   Second, the sepsis-3 definition was published 
during the study period. Therefore, in many patients, 
the results of coagulation tests were not available, 
making it impossible to include SOFA scores for all 
patients. However, as the patients in this study were 
suspected of having an infection, we believe that the 
results were not greatly affected without the SOFA 
score evaluation.
   Finally, this finding may have been influenced by 
the higher levels of PSEP observed even without 
the presence of infection in renal dysfunction and 
dialysis patients22）, indicating that false-positive 
results may frequently be seen in these patients.
   In conclusion, both PSEP and PCT demonstrated 
good predictive ability for bacteremia in patients 
suspected of infection. Using the cut-off values 
determined in our analysis, we achieved a clinically 
useful NPV. PSEP and PCT may be useful for ruling 
out bacteremia.
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